Social Pulse: Forest Laboratories Inc (FRX)
FRX on New York Consolidated
39.53USD
23 May 2013
39.53USD
23 May 2013
Price Change (% chg)
$2.02 (+5.39%)
$2.02 (+5.39%)
Prev Close
$37.51
$37.51
Open
$38.01
$38.01
Day's High
$39.67
$39.67
Day's Low
$38.01
$38.01
Volume
4,032,566
4,032,566
Avg. Vol
1,355,468
1,355,468
52-wk High
$39.67
$39.67
52-wk Low
$31.28
$31.28
Press Releases
- Ironwood and Forest Announce U.S. Availability of LINZESS (Linaclotide)
- Forest Laboratories and Almirall announce commercial availability of Tudorza Pressair in US pharmacies
- Forest Laboratories, Inc. to Present Cariprazine Results from a Phase 3 Trial and Two Pharmacology Studies at the American College of Neuropsychopharmacology (ACNP) Annual Meeting
- Forest Laboratories, Inc. Announces Additional Settlement Agreements in BYSTOLIC Patent Litigation
- Forest Laboratories Submits New Drug Application for Cariprazine for the Treatment of Both Schizophrenia and Manic or Mixed Episodes Associated with Bipolar I Disorder
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
